Walleye Trading
ALT icon

Walleye Trading’s Altimmune ALT Stock Holding History

Walleye Trading’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32,200
Closed -$116K – 4076
2025
Q4 		$116K Buy
+32,200
New +$140K ﹤0.01% 3670
2025
Q3 		– Sell
-500
Closed -$1.94K – 4328
2025
Q2 		$1.94K Buy
+500
New +$2.71K ﹤0.01% 4131
2025
Q1 		– Sell
-6,700
Closed -$48.3K – 4006
2024
Q4 		$48.3K Buy
+6,700
New +$51.2K ﹤0.01% 3801
2024
Q2 		– Sell
-10,500
Closed -$107K – 4223
2024
Q1 		$107K Buy
+10,500
New +$107K ﹤0.01% 3735
2023
Q1 		– Sell
-1,400
Closed -$23K – 4802
2022
Q4 		$23K Buy
+1,400
New +$15.7K ﹤0.01% 4351
2022
Q1 		– Sell
-92,300
Closed -$845K – 5265
2021
Q4 		$845K Buy
+92,300
New +$981K ﹤0.01% 2388

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Walleye Trading's ALT Position: Q4 2025 in Review

Walleye Trading sold out of Altimmune (ALT) in Q4 2025, closing a stake of 14,759 shares — an estimated $64.3K sold.

Walleye Trading first reported a position in ALT in Q3 2013 and held it in 16 quarters. The position peaked at $1.29M in Q4 2022. 181 funds tracked by Wall St. Rank hold ALT as of Q4 2025.

  • Walleye Trading reported no remaining Altimmune position as of Q4 2025 after selling out during the quarter.
  • Walleye Trading sold 14,759 Altimmune shares in Q4 2025, an estimated $64.3K.
  • Walleye Trading first reported a position in Altimmune in Q3 2013 and held it in 16 quarters.
  • Walleye Trading's Altimmune position peaked at $1.29M in Q4 2022.
  • 181 funds tracked by Wall St. Rank held Altimmune as of Q4 2025.

Based on Walleye Trading's 13F filing for Q4 2025, filed 13 Feb 2026.